Lyme disease, a potentially debilitating tick-borne infection if it is left untreated, is a growing problem in parts of Canada, with thousands of reported cases. But could there soon be a vaccine?

Big pharmaceutical companies are seeing Chinese biotech as the disruptors. Read more at straitstimes.com. Read more at straitstimes.com.

Financial disclosure records show that members of the vaccine safety panel fired by HHS Secretary RFK Jr. had financial ties to the pharmaceutical industry.

Four blue-chip stocks are trading near their 52-week lows and offering investors incredible entry points and huge dividends.

Major vaccine policy changes could be on the horizon as the HHS removes key advisors. Click for my thoughts on what this may ...

As winter settles over Australia, it's not just the drop in temperature we notice—there's also a sharp rise in respiratory ...

As President Donald Trump vows to bridge the drug pricing gap between the U.S. and other developed countries with his “most ...

While the news isn’t great for vaccine manufacturers, it could have been worse. Shares of pure vaccine play Moderna rose 0.3% ...

Pfizer CEO Albert Bourla has pulled back the curtain on his $1.25 billion bet on a PD-1xVEGF bispecific, revealing that his ...

(Reuters) -Shares of global vaccine makers were muted on Tuesday as investors and analysts took a "wait and watch" approach ...

Dividend stocks are one way to shield yourself from the market volatility. While all stocks carry a certain element of risk, ...

Pfizer offers a high 7.4% dividend yield and trades at low valuation multiples. Click here to read more about PFE stock and ...